Articles

Export this record

Export selected records

Export record to excel

File type to download

Beta version

Record title

Immunomodulatory activity of lenvatinib contributes to antitumor activity in the Hepa1‐6 hepatocellular carcinoma model

Record identifier

TN_cdi_proquest_journals_2287988061

Immunomodulatory activity of lenvatinib contributes to antitumor activity in the Hepa1‐6 hepatocellular carcinoma model

ACCESS
https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2287988061

Immunomodulatory activity of lenvatinib contributes to antitumor activity in the Hepa1‐6 hepatocellular carcinoma model

Full title

Immunomodulatory activity of lenvatinib contributes to antitumor activity in the Hepa1‐6 hepatocellular carcinoma model

Publisher

England: Wiley Subscription Services, Inc

Journal title

Cancer science, 2018, Vol.109 (12), p.3993-4002

Record Identifier

TN_cdi_proquest_journals_2287988061

Language

English

Formats

Publication information

Publisher

Subjects

Subjects and topics

Analysis Angiogenesis inhibitors Animals Antibodies Antimitotic agents Antineoplastic agents Antineoplastic Agents - administration & dosage Antineoplastic Agents - pharmacology Antineoplastic Agents, Immunological - administration & dosage Antineoplastic Agents, Immunological - pharmacology Antitumor activity anti‐PD‐1 antibody Apoptosis Cancer therapies Carcinoma, Hepatocellular - drug therapy Carcinoma, Hepatocellular - genetics Carcinoma, Hepatocellular - immunology CD8 antigen CD8-Positive T-Lymphocytes - cytology CD8-Positive T-Lymphocytes - drug effects Cell death Cell Line, Tumor Cell Proliferation - drug effects Cell Survival - drug effects Clinical trials Enzyme inhibitors Fibroblast growth factor Fibroblast growth factor receptor 1 Growth factors Hepatocellular carcinoma Hepatoma Immune checkpoint inhibitors Immunocompetence Immunodeficiency Immunomodulation immunomodulatory activity Kinases Laboratories lenvatinib Liver cancer Liver Neoplasms - drug therapy Liver Neoplasms - genetics Liver Neoplasms - immunology Lymphocytes Lymphocytes T Macrophages Metastasis Mice Monoclonal antibodies Monocytes Mortality Original PD-1 protein Phenylurea Compounds - administration & dosage Phenylurea Compounds - pharmacology Programmed Cell Death 1 Receptor - antagonists & inhibitors Protein-tyrosine kinase Protein-tyrosine kinase receptors Quinolines - administration & dosage Quinolines - pharmacology Response rates Ret protein Ribonucleic acid RNA RNA sequencing Sequence Analysis, RNA Single-Cell Analysis sorafenib Sorafenib - administration & dosage Sorafenib - pharmacology T cells Targeted cancer therapy Thyroid cancer Tumors Vascular endothelial growth factor Viral antibodies Xenograft Model Antitumor Assays

More information

SCOPE AND CONTENTS

Contents

ALTERNATIVE TITLES

Full title

Identifiers

PRIMARY IDENTIFIERS

Record Identifier

TN_cdi_proquest_journals_2287988061

Permalink

https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2287988061

OTHER IDENTIFIERS

ISSN

E-ISSN

DOI

How to access this item

Online

1 item

How to access?

Login with a Library card